HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases
Open Access
- 1 January 2010
- journal article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 6 (1) , 15
- https://doi.org/10.1186/1746-6148-6-15
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumoursThe Veterinary Journal, 2010
- Loss of p27 expression in canine mammary tumors and their metastasesResearch in Veterinary Science, 2010
- Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glandsResearch in Veterinary Science, 2009
- Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cellsCarcinogenesis: Integrative Cancer Research, 2008
- Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expressionBMC Cancer, 2007
- Expression of Connexins 26 and 43 in Canine Hyperplastic and Neoplastic Mammary GlandsVeterinary Pathology, 2005
- Cadherins and the mammary glandJournal of Cellular Biochemistry, 2005
- Role of transforming growth factor β in breast carcinogenesisThe Lancet Oncology, 2004
- Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumorsVeterinary Research, 2003
- Paxillin: a focal adhesion-associated adaptor proteinOncogene, 2001